Structure Therapeutics IncNASDAQ:GPCR
- LAST PRICE38.1600
- TODAY'S CHANGE (%)-1.8400 (-4.6000%)
- Bid / Lots38.0600/ 4
- Ask / Lots38.2400/ 1
- Open / Previous Close39.7900 / 40.0000
- Day Range
- 52 Week Range
- Volume223,745
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GPCR |
|---|---|---|
| 09:32 ET | 3740 | 39.31 |
| 09:34 ET | 547 | 39.3519 |
| 09:36 ET | 300 | 38.98 |
| 09:38 ET | 3245 | 38.91 |
| 09:39 ET | 2781 | 39.1 |
| 09:41 ET | 830 | 39.41 |
| 09:43 ET | 1000 | 39.675 |
| 09:45 ET | 576 | 39.65 |
| 09:48 ET | 1670 | 39.51 |
| 09:50 ET | 1728 | 39.42 |
| 09:52 ET | 1326 | 39.505 |
| 09:54 ET | 2050 | 39.48 |
| 09:56 ET | 1145 | 39.63 |
| 09:57 ET | 1773 | 39.98 |
| 09:59 ET | 1280 | 39.95 |
| 10:01 ET | 2508 | 39.8 |
| 10:03 ET | 3940 | 39.485 |
| 10:06 ET | 2197 | 39.435 |
| 10:08 ET | 1266 | 39.42 |
| 10:10 ET | 8025 | 39.35 |
| 10:12 ET | 3912 | 39.21 |
| 10:14 ET | 700 | 39.38 |
| 10:15 ET | 200 | 39.275 |
| 10:17 ET | 795 | 38.98 |
| 10:19 ET | 100 | 38.85 |
| 10:21 ET | 400 | 38.88 |
| 10:24 ET | 100 | 38.98 |
| 10:26 ET | 4205 | 38.975 |
| 10:28 ET | 14135 | 39 |
| 10:30 ET | 3508 | 39.015 |
| 10:32 ET | 4040 | 39 |
| 10:33 ET | 905 | 38.89 |
| 10:35 ET | 350 | 38.87 |
| 10:37 ET | 5140 | 38.87 |
| 10:42 ET | 400 | 38.82 |
| 10:44 ET | 100 | 38.86 |
| 10:46 ET | 900 | 38.78 |
| 10:48 ET | 200 | 38.79 |
| 10:50 ET | 605 | 38.82 |
| 10:51 ET | 3131 | 38.5 |
| 10:53 ET | 1400 | 38.48 |
| 10:55 ET | 2938 | 38.345 |
| 11:00 ET | 1765 | 38.4 |
| 11:02 ET | 5700 | 38.5127 |
| 11:04 ET | 1505 | 38.675 |
| 11:06 ET | 430 | 38.685 |
| 11:08 ET | 1360 | 38.79 |
| 11:09 ET | 5600 | 38.82 |
| 11:11 ET | 100 | 38.82 |
| 11:13 ET | 1000 | 38.74 |
| 11:18 ET | 1817 | 38.79 |
| 11:22 ET | 4312 | 38.39 |
| 11:24 ET | 430 | 38.4829 |
| 11:26 ET | 200 | 38.4692 |
| 11:27 ET | 700 | 38.445 |
| 11:29 ET | 1070 | 38.4 |
| 11:31 ET | 340 | 38.35 |
| 11:33 ET | 2390 | 38.265 |
| 11:36 ET | 2919 | 38.36 |
| 11:38 ET | 400 | 38.365 |
| 11:40 ET | 2053 | 38.35 |
| 11:42 ET | 4208 | 38.295 |
| 11:44 ET | 1864 | 38.39 |
| 11:45 ET | 300 | 38.425 |
| 11:47 ET | 573 | 38.37 |
| 11:49 ET | 711 | 38.32 |
| 11:51 ET | 3395 | 38.18 |
| 11:54 ET | 523 | 38.13 |
| 11:56 ET | 6075 | 38.2599 |
| 11:58 ET | 2825 | 38.29 |
| 12:00 ET | 2831 | 38.385 |
| 12:02 ET | 10690 | 38.27 |
| 12:03 ET | 2265 | 38.26 |
| 12:05 ET | 1607 | 38.25 |
| 12:07 ET | 200 | 38.2643 |
| 12:09 ET | 500 | 38.27 |
| 12:12 ET | 400 | 38.27 |
| 12:14 ET | 310 | 38.27 |
| 12:16 ET | 1000 | 38.275 |
| 12:18 ET | 200 | 38.275 |
| 12:20 ET | 700 | 38.29 |
| 12:21 ET | 2106 | 38.262 |
| 12:23 ET | 1207 | 38.115 |
| 12:25 ET | 1458 | 38.095 |
| 12:27 ET | 563 | 38.095 |
| 12:30 ET | 2438 | 38.36 |
| 12:32 ET | 400 | 38.315 |
| 12:34 ET | 300 | 38.315 |
| 12:36 ET | 1000 | 38.315 |
| 12:38 ET | 637 | 38.35 |
| 12:39 ET | 1200 | 38.21 |
| 12:41 ET | 1095 | 38.115 |
| 12:43 ET | 1494 | 38.21 |
Yesterday
DJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:30AM ET on Monday Jul 01, 2024 by Dow Jones
9:30AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 20, 2024
DJ Obesity-Drug Developers Look at What's Next for a $100 Billion Market -- Barrons.com, from 2:51PM ET on Thursday Jun 20, 2024 by Dow Jones
2:51PM ET on Thursday Jun 20, 2024 by Dow JonesDJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 1:03PM ET on Thursday Jun 20, 2024 by Dow Jones
1:03PM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 17, 2024
DJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 1:41PM ET on Monday Jun 17, 2024 by Dow Jones
1:41PM ET on Monday Jun 17, 2024 by Dow Jones
Jun 7, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Structure Therapeutics Inc | 2.3B | -16.5x | --- |
Apogee Therapeutics Inc | 2.3B | -18.6x | --- |
Iovance Biotherapeutics Inc | 2.3B | -4.3x | --- |
CG Oncology Inc | 2.1B | -27.8x | --- |
Janux Therapeutics Inc | 2.2B | -32.7x | --- |
Geron Corp | 2.6B | -12.0x | --- |
Company Information
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Contact Information
- Headquarters
- 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Daniel Welch
- Chief Executive Officer, Director
- Raymond Stevens
- Chief Financial Officer
- Jun Yoon
- Chief Technology Officer
- Yingli Ma
- Chief Scientific Officer
- Xichen Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -16.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
